Prescription Required
Arpimune ME
Prescription Required
Arpimune ME Information
Arpimune ME Benefits & Uses
Arpimune ME is used to treat the following -
- Rheumatoid Arthritis
- Psoriasis Primary
- Kidney transplant
- Liver transplant Primary
- Dry Eye Syndrome
Arpimune ME Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Log in to view medicine dosage
Ingredients of Arpimune ME
Arpimune ME Side Effects
Based on research, the following side effects have been observed when Arpimune ME is used -
- Headache Severe
- Nausea or vomiting
- Increased hair growth
- Increased blood pressure
- Renal Impairment
- Loss of appetite
- Diarrhoea
- Tremor
- Skin Rash Severe
- Fever Severe
- Abdominal Pain
- Blurred vision
- Dark colored (brown) urine
- Chest Pain
- Cough
- Bleeding Gums
- Indigestion
- Constipation
Arpimune ME Related Warnings
Is the use of Arpimune ME safe for pregnant women?
Those womens are pregnant, before taking Arpimune ME should be consult to doctor. If you don't do same, Then it will cause some serious side effects on your body.
Is the use of Arpimune ME safe during breastfeeding?
Women who are breastfeeding, may suffer serious consequences after taking Arpimune ME. So don't take this drug without consulting your doctor first, otherwise it may be dangerous for you.
What is the effect of Arpimune ME on the Kidneys?
Very few cases of side effects of Arpimune ME on [Organ] have been reported.
What is the effect of Arpimune ME on the Liver?
Side effects of Arpimune ME rarely affect the [Organ].
What is the effect of Arpimune ME on the Heart?
Arpimune ME may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Severe Interaction of Arpimune ME with Other Drugs
Arpimune ME should not be taken with following medicines due to severe side effects it may cause to patients -
Arpimune ME Contraindications
If you are suffering from any of the following diseases, you should not take Arpimune ME unless your doctor advises you to do so -
- Stomach ache
- Back Pain
- Chest Pain
- Dizziness
- Fever
- Headache
- Skin Rash
- Shortness of Breath
- Bleeding
- Constipation
- Liver Disease
- Allergy
- Psoriasis
- Kidney Disease
- Rheumatoid Arthritis
- High Cholesterol
- High BP (High Blood Pressure)
- Liver Disease
- Kidney Disease
- High Uric Acid Levels in the Blood
Frequently asked Questions about Arpimune ME
Is this Arpimune ME habit forming or addictive?
No, there is no any evidence that Arpimune ME is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Arpimune ME as it does not make you drowsy.
Is it safe?
" Yes, Arpimune ME it is safe but take it after seeking your doctor's advice."
Is it able to treat mental disorders?
No, Arpimune ME is not used to treat mental disorders.
Arpimune ME Interactions with Food and Alcohol
Interaction between Food and Arpimune ME
There is no information on the effects of food and Arpimune ME because this topic has not been scientifically researched yet.
Interaction between Alcohol and Arpimune ME
Due to lack of research, there is no information about the side effects of taking Arpimune ME with alcohol.
Details
| सामग्री | 5 Capsules(S) |
See all substitutes for Arpimune ME
| Medicine Name | |
|---|---|
| Arpimune ME | खरीदें |
| Cyclophil ME | खरीदें |
| Graftin | खरीदें |
| Panimun Bioral | खरीदें |
Select Language Preference
References
- US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
- KD Tripathi. Essentials of Medical Pharmacology. Eighth Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2019
- April Hazard Vallerand, Cynthia A. Sanoski. Davis’s Drug Guide For Nurses. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380
